Skip to main content
Premium Trial:

Request an Annual Quote

Immunicon Licenses Kreatech s Univeral Linkage System Technology

NEW YORK, Jan. 6 (GenomeWeb News) - Immunicon has licensed from Amsterdam-based Kreatech Biotech the right to use its Universal Linkage System technology, the companies said yesterday.


Previously, Immunicon evaluated ULS-labeled centromere probes for detection of abnormalities common to cancer cells.


Immunicon plans to develop assays that could confirm whether certain cells of epithelial origin in a patient's blood sample are cancerous.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.